Press Release:- The Caribbean Public Health Agency (CARPHA) is urging Ministries of Health and clinicians to only use the medicine, ivermectin, under the conditions of well-regulated clinical trials for COVID-19, or for approved indications. This is a result of the limited evidence available to assure a favorable benefit-risk balance when used in treating patients with COVID-19. […]
This article CARPHA Speaks On Use Of Ivermectin To Treat COVID-19 appeared first on St. Lucia Times News.
